Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · IEX Real-Time Price · USD
37.98
+0.03 (0.08%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $4.61 billion as of July 22, 2024. Its market cap has decreased by -54.60% in one year.
Market Cap
4.61B
Enterprise Value
4.39B
1-Year Change
-54.60%
Ranking
Category
Stock Price
$37.98
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.10M to $4.61B, an increase of 566.98%. That is a compound annual growth rate of 32.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 4.61B | -35.02% |
| Dec 29, 2023 | 7.09B | 24.06% |
| Dec 30, 2022 | 5.72B | 38.54% |
| Dec 31, 2021 | 4.13B | -4.73% |
| Dec 31, 2020 | 4.33B | 121.45% |
| Dec 31, 2019 | 1.96B | 163.72% |
| Dec 31, 2018 | 741.80M | -32.09% |
| Dec 29, 2017 | 1.09B | 58.05% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Select Medical Holdings | 4.95B |
| PACS Group | 4.92B |
| BridgeBio Pharma | 4.90B |
| TransMedics Group | 4.85B |
| CRISPR Therapeutics AG | 4.63B |
| RadNet | 4.58B |
| Haemonetics | 4.52B |
| Avidity Biosciences | 4.32B |